Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2026.
Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2026.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Imposes a hospital licensing fee for fiscal year 2026 against net patient-services revenue of every non-government owned hospital for the hospital’s first fiscal year ending on or after January 1, 2024.
Imposes a hospital licensing fee for fiscal year 2026 against net patient-services revenue of every non-government owned hospital for the hospital’s first fiscal year ending on or after January 1, 2024.
Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment, test, exam, study, procedure, or any generic or brand name prescription drug ordered by a primary care provider.
Prohibits health insurance plans from requiring prior authorization for a new episode of rehabilitative care for twelve visits, or from requiring prior authorization for rehabilitative care for chronic pain for ninety days.
Limits prior authorization requirements for rehabilitative and habilitative services. Also prohibits prior authorization for the first twelve (12) visits of a new episode of care and for ninety (90) days following a chronic pain diagnosis.